# Blum Holdings, Inc.: financial statements, quarterly

BLMH · OTC · CIK 1996210 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/blmh.md) · [Financials](/companies/blmh/financials.md) · [Filings](/companies/blmh/filings.md) · [Insiders](/companies/blmh/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/blmh/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.6](/filings/0001437749-24-016719.md) | [2.3](/filings/0001437749-24-026796.md) | [1.5](/filings/0001437749-24-034570.md) | [2.1 d](/filings/0001437749-25-007468.md) | [1.8](/filings/0001437749-25-016732.md) | [3.8](/filings/0001437749-25-026484.md) | [4.4](/filings/0001437749-25-034958.md) | [3.1 d](/filings/0001437749-25-007468.md) | [2.2](/filings/0001437749-25-016732.md) | [3.5](/filings/0001437749-25-026484.md) | [4.8](/filings/0001437749-25-034958.md) |
| Cost of revenue | $m | [3.9](/filings/0001437749-24-016719.md) | [1.1](/filings/0001437749-24-026796.md) | [1.0](/filings/0001437749-24-034570.md) | [1.0 d](/filings/0001437749-25-007468.md) | [1.0](/filings/0001437749-25-016732.md) | [2.2](/filings/0001437749-25-026484.md) | [1.9](/filings/0001437749-25-034958.md) | [1.7 d](/filings/0001437749-25-007468.md) | [1.0](/filings/0001437749-25-016732.md) | [1.8](/filings/0001437749-25-026484.md) | [2.5](/filings/0001437749-25-034958.md) |
| Gross profit | $m | [4.7](/filings/0001437749-24-016719.md) | [1.2](/filings/0001437749-24-026796.md) | [0.5](/filings/0001437749-24-034570.md) | [1.1 d](/filings/0001437749-25-007468.md) | [0.8](/filings/0001437749-25-016732.md) | [1.6](/filings/0001437749-25-026484.md) | [2.4](/filings/0001437749-25-034958.md) | [1.4 d](/filings/0001437749-25-007468.md) | [1.2](/filings/0001437749-25-016732.md) | [1.7](/filings/0001437749-25-026484.md) | [2.3](/filings/0001437749-25-034958.md) |
| Selling, general and administrative | $m | [5.5](/filings/0001437749-24-016719.md) | [5.7](/filings/0001437749-24-026796.md) | [4.9](/filings/0001437749-24-034570.md) | [6.9 d](/filings/0001437749-25-007468.md) | [4.4](/filings/0001437749-25-016732.md) | [6.2](/filings/0001437749-25-026484.md) | [4.3](/filings/0001437749-25-034958.md) | [3.7 d](/filings/0001437749-25-007468.md) | [2.5](/filings/0001437749-25-016732.md) | [2.5](/filings/0001437749-25-026484.md) | [3.8](/filings/0001437749-25-034958.md) |
| Operating income | $m | [(0.9)](/filings/0001437749-24-016719.md) | [(4.6)](/filings/0001437749-24-026796.md) | [(5.9)](/filings/0001437749-24-034570.md) | [(5.8) d](/filings/0001437749-25-007468.md) | [(3.6)](/filings/0001437749-25-016732.md) | [(6.4)](/filings/0001437749-25-026484.md) | [(2.2)](/filings/0001437749-25-034958.md) | [17.6 d](/filings/0001437749-25-007468.md) | [(1.3)](/filings/0001437749-25-016732.md) | [(0.8)](/filings/0001437749-25-026484.md) | [(1.5)](/filings/0001437749-25-034958.md) |
| Income tax | $m | [0.7](/filings/0001437749-24-016719.md) | [(0.1)](/filings/0001437749-24-026796.md) | [0.0](/filings/0001437749-24-034570.md) | [0.6 d](/filings/0001437749-25-007468.md) | [0.0](/filings/0001437749-25-016732.md) | [0.3](/filings/0001437749-25-026484.md) | [0.4](/filings/0001437749-25-034958.md) | [0.7 d](/filings/0001437749-25-007468.md) | [0.2](/filings/0001437749-25-016732.md) | [0.3](/filings/0001437749-25-026484.md) | [0.5](/filings/0001437749-25-034958.md) |
| Net income | $m | [0.4](/filings/0001437749-24-016719.md) | [(3.2)](/filings/0001437749-24-026796.md) | [(3.4)](/filings/0001437749-24-034570.md) | [(7.9) d](/filings/0001437749-24-012085.md) | [(3.1)](/filings/0001437749-25-016732.md) | [23.8](/filings/0001437749-25-026484.md) | [(3.3)](/filings/0001437749-25-034958.md) | [15.7 d](/filings/0001437749-25-007468.md) | [(0.6)](/filings/0001437749-25-016732.md) | [(1.9)](/filings/0001437749-25-026484.md) | [(2.6)](/filings/0001437749-25-034958.md) |
| Basic EPS | $ per share | not reported | [(0.39)](/filings/0001437749-24-012085.md) | [(0.35)](/filings/0001437749-24-012085.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [1.2](/filings/0001437749-24-012085.md) | not reported | [0.6](/filings/0001437749-24-012085.md) | [2.0](/filings/0001437749-24-012085.md) | [0.4](/filings/0001437749-25-007468.md) | [1.2](/filings/0001437749-24-016719.md) | [1.6](/filings/0001437749-24-026796.md) | [1.0](/filings/0001437749-24-034570.md) | [1.0](/filings/0001437749-25-034958.md) | [0.4](/filings/0001437749-25-016732.md) | [0.4](/filings/0001437749-25-026484.md) | [0.4](/filings/0001437749-25-034958.md) |
| Current assets | $m | [4.6](/filings/0001437749-24-012085.md) | not reported | [5.7](/filings/0001437749-24-012085.md) | [7.0](/filings/0001437749-24-012085.md) | [4.7](/filings/0001437749-25-007468.md) | [4.9](/filings/0001437749-24-016719.md) | [4.5](/filings/0001437749-24-026796.md) | [3.5](/filings/0001437749-24-034570.md) | [2.9](/filings/0001437749-25-034958.md) | [2.0](/filings/0001437749-25-016732.md) | [1.7](/filings/0001437749-25-026484.md) | [1.7](/filings/0001437749-25-034958.md) |
| Total assets | $m | [40.5](/filings/0001437749-24-012085.md) | [39.5](/filings/0001437749-24-016719.md) | [38.4](/filings/0001437749-24-026796.md) | [36.5](/filings/0001437749-24-034570.md) | [32.1](/filings/0001437749-25-007468.md) | [32.0](/filings/0001437749-25-016732.md) | [38.3](/filings/0001437749-25-026484.md) | [38.7](/filings/0001437749-25-034958.md) | [24.8](/filings/0001437749-25-034958.md) | [23.8](/filings/0001437749-25-016732.md) | [39.4](/filings/0001437749-25-026484.md) | [45.1](/filings/0001437749-25-034958.md) |
| Current liabilities | $m | [59.1](/filings/0001437749-24-012085.md) | not reported | [54.6](/filings/0001437749-24-012085.md) | [60.8](/filings/0001437749-24-012085.md) | [62.5](/filings/0001437749-25-007468.md) | [65.7](/filings/0001437749-24-016719.md) | [49.7](/filings/0001437749-24-026796.md) | [51.9](/filings/0001437749-24-034570.md) | [9.7](/filings/0001437749-25-034958.md) | [9.5](/filings/0001437749-25-016732.md) | [22.5](/filings/0001437749-25-026484.md) | [25.4](/filings/0001437749-25-034958.md) |
| Total liabilities | $m | [77.0](/filings/0001437749-24-012085.md) | not reported | [73.6](/filings/0001437749-24-012085.md) | [75.1](/filings/0001437749-24-012085.md) | [77.8](/filings/0001437749-25-007468.md) | [80.6](/filings/0001437749-24-016719.md) | [62.1](/filings/0001437749-24-026796.md) | [66.2](/filings/0001437749-24-034570.md) | [29.6](/filings/0001437749-25-034958.md) | [29.0](/filings/0001437749-25-016732.md) | [46.0](/filings/0001437749-25-026484.md) | [52.3](/filings/0001437749-25-034958.md) |
| Long-term debt | $m | [4.8](/filings/0001437749-24-012085.md) | not reported | not reported | not reported | [6.5](/filings/0001437749-25-007468.md) | [6.5](/filings/0001437749-24-016719.md) | [5.6](/filings/0001437749-24-026796.md) | [5.4](/filings/0001437749-24-034570.md) | [2.3](/filings/0001437749-25-034958.md) | [2.3](/filings/0001437749-25-016732.md) | [3.7](/filings/0001437749-25-026484.md) | [4.0](/filings/0001437749-25-034958.md) |
| Current portion of debt | $m | [29.7](/filings/0001437749-24-012085.md) | not reported | not reported | not reported | [22.6](/filings/0001437749-25-007468.md) | [22.6](/filings/0001437749-24-016719.md) | [3.7](/filings/0001437749-24-026796.md) | [3.8](/filings/0001437749-24-034570.md) | [0.7](/filings/0001437749-25-034958.md) | [0.8](/filings/0001437749-25-016732.md) | [1.1](/filings/0001437749-25-026484.md) | [1.1](/filings/0001437749-25-034958.md) |
| Shareholders' equity | $m | [(36.5)](/filings/0001437749-24-012085.md) | [(33.7)](/filings/0001437749-24-026796.md) | [(35.3)](/filings/0001437749-24-012085.md) | [(38.6)](/filings/0001437749-24-012085.md) | [(45.7)](/filings/0001437749-25-016732.md) | [(48.6)](/filings/0001437749-25-016732.md) | [(24.0)](/filings/0001437749-24-026796.md) | [(28.2)](/filings/0001437749-24-034570.md) | [(6.7)](/filings/0001437749-25-034958.md) | [(7.7)](/filings/0001437749-25-016732.md) | [(9.4)](/filings/0001437749-25-026484.md) | [(11.9)](/filings/0001437749-25-034958.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,212)](/filings/0001437749-24-016719.md) | [972 d](/filings/0001437749-24-026796.md) | [760 d](/filings/0001437749-24-034570.md) | [(506) d](/filings/0001437749-25-007468.md) | [(733)](/filings/0001437749-25-016732.md) | [(117) d](/filings/0001437749-25-026484.md) | [(458) d](/filings/0001437749-25-034958.md) | [(241) d](/filings/0001437749-25-007468.md) | [(364)](/filings/0001437749-25-016732.md) | [(486) d](/filings/0001437749-25-026484.md) | [(658) d](/filings/0001437749-25-034958.md) |
| Capital expenditure | $k | [153](/filings/0001437749-24-016719.md) | [(91.0) d](/filings/0001437749-24-026796.md) | [68.0 d](/filings/0001437749-24-034570.md) | [181 d](/filings/0001437749-25-007468.md) | [32.0](/filings/0001437749-25-016732.md) | [(26.0) d](/filings/0001437749-25-026484.md) | [2.0 d](/filings/0001437749-25-034958.md) | [2.0 d](/filings/0001437749-25-007468.md) | [0.0](/filings/0001437749-25-016732.md) | [10.0 d](/filings/0001437749-25-026484.md) | [25.0 d](/filings/0001437749-25-034958.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [8.4](/filings/0001437749-24-016719.md) | [8.4](/filings/0001437749-24-026796.md) | [9.7](/filings/0001437749-24-034570.md) | [9.9](/filings/0001437749-25-016732.md) | [11.0](/filings/0001437749-25-026484.md) | [9.7](/filings/0001437749-24-034570.md) | [12.3](/filings/0001437749-25-016732.md) | [12.3](/filings/0001437749-25-026484.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,230,686 at 2025-11-13, from the cover of the [10-Q filed 2025-11-14](/filings/0001437749-25-034958.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.